Compare WELL & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WELL | ELV |
|---|---|---|
| Founded | 1970 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.1B | 85.7B |
| IPO Year | 1994 | 2001 |
| Metric | WELL | ELV |
|---|---|---|
| Price | $206.95 | $415.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 19 |
| Target Price | $224.38 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 2.9M | 1.4M |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | 1.40% | ★ 1.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.02 | ★ 8.00 |
| Revenue | $10,838,034,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $28.56 | N/A |
| Revenue Next Year | $6.97 | $3.07 |
| P/E Ratio | $196.38 | ★ $51.17 |
| Revenue Growth | ★ 35.63 | 12.49 |
| 52 Week Low | $148.60 | $273.71 |
| 52 Week High | $221.68 | $411.80 |
| Indicator | WELL | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 49.86 | 68.74 |
| Support Level | $199.04 | $307.16 |
| Resistance Level | $213.76 | N/A |
| Average True Range (ATR) | 5.55 | 9.81 |
| MACD | -1.53 | -0.87 |
| Stochastic Oscillator | 56.92 | 92.56 |
Welltower owns a diversified healthcare portfolio of 2,800 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.